- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00237016
Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever
Abstract Background Tick-Borne Relapsing Fever (TBRF) is an acute febrile illness. In Israel, TBRF is caused by Borrelia persica and is transmitted by Ornithodoros tholozani ticks. We examined the safety and efficacy of a post exposure treatment policy to prevent TBRF.
Methods In a double blind, placebo controlled trial 93 healthy volunteers with suspected tick exposure (51 with bite signs and 42 contacts) were randomly assigned to receive either Doxycycline (200 mg for the first day and 100mg/d for 4 days) or placebo, approximately 2 days after contact. Blood smears were examined for Borrelia at inclusion and during fever rise. Serology for Lyme disease cross- reactivity and PCR for Borrelia GlpQ gene were also performed. Cases of TBRF were defined as subjects having fever and a positive blood smear.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Tel Hashomer, Israel
- Israel Defence Forces
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- suspected exposure to tick-borne relapsing fever
- after returning from field exercise in a tick-borne relapsing fever infected area
- having a tick bite or staying in field in close proximity to a subject with tick bite sign
Exclusion Criteria:
- known sensitivity to tetracycline or doxycycline
- febrile illness on recruitment
Study Plan
How is the study designed?
Design Details
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Collaborators and Investigators
Investigators
- Principal Investigator: Tal Hasin, MD, Medical corps, Israel Defence Forces
Publications and helpful links
General Publications
- Nadelman RB, Nowakowski J, Fish D, Falco RC, Freeman K, McKenna D, Welch P, Marcus R, Aguero-Rosenfeld ME, Dennis DT, Wormser GP; Tick Bite Study Group. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med. 2001 Jul 12;345(2):79-84. doi: 10.1056/NEJM200107123450201.
- Hasin T, Davidovitch N, Cohen R, Dagan T, Romem A, Orr N, Klement E, Lubezky N, Kayouf R, Sela T, Keller N, Derazne E, Halperin T, Yavzori M, Grotto I, Cohen D. Postexposure treatment with doxycycline for the prevention of tick-borne relapsing fever. N Engl J Med. 2006 Jul 13;355(2):148-55. doi: 10.1056/NEJMoa053884.
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Infections
- Vector Borne Diseases
- Gram-Negative Bacterial Infections
- Bacterial Infections
- Bacterial Infections and Mycoses
- Body Temperature Changes
- Tick-Borne Diseases
- Borrelia Infections
- Spirochaetales Infections
- Fever
- Relapsing Fever
- Anti-Infective Agents
- Anti-Bacterial Agents
- Antiprotozoal Agents
- Antiparasitic Agents
- Antimalarials
- Doxycycline
Other Study ID Numbers
- RF1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Jarisch Herxheimer Reaction
-
Institut PasteurRecruitingLeptospirosis | Jarisch Herxheimer ReactionNew Caledonia
-
PT Bio FarmaCenter for Child Health Universitas Gadjah Mada (CCH-PRO UGM; Cipto Mangunkusumo... and other collaboratorsRecruitingVaccine Adverse Reaction | Vaccine ReactionIndonesia
-
China Medical University HospitalCompletedReaction of Autonomic Nervous System | Reaction of Acupuncture | Reaction of Blood CirculationTaiwan
-
China Medical University HospitalCompletedReaction of Autonomic Nervous System | Reaction of Acupuncture | Reaction of Far Infrared RayTaiwan
-
Galeno Desenvolvimento de Pesquisas ClínicasBiolab Sanus FarmaceuticaCompletedLidocaine Adverse Reaction | Prilocaine Adverse ReactionBrazil
-
China Medical University HospitalCompletedReaction of Far Infrared Ray | Reaction of Skin TemperatureTaiwan
-
University of Texas Southwestern Medical CenterRecruitingAnesthesia | Anesthesia; Reaction | Anesthesia Complication | Anesthesia; Adverse Effect | Propofol Adverse Reaction | Etomidate Adverse ReactionUnited States
-
Clinical Hospital Center ZemunWithdrawnBisoprolol Adverse Reaction | Nebivolol Adverse ReactionSerbia
-
The Leeds Teaching Hospitals NHS TrustLeeds Clinical Commissioning GroupRecruitingAdherence, Medication | Statin Adverse Reaction | Anticoagulant Adverse ReactionUnited Kingdom
-
Rigshospitalet, DenmarkUnknownAnalgesic Adverse Reaction | Gonad Regulating Hormone Adverse ReactionDenmark
Clinical Trials on doxycycline treatment
-
Aljazeera HospitalUnknown
-
Centers for Disease Control and PreventionCompleted
-
University Hospital, BordeauxUSC EA 3671 Infections humaines à mycoplasmes et à chlamydiaeUnknownChlamydia Trachomatis Infection | Vaginal Infection | Anal InfectionFrance
-
National Institute of Allergy and Infectious Diseases...Completed
-
Massachusetts General HospitalNanoSHIFT LLCRecruiting
-
Russian Academy of Medical SciencesUnknownCardiovascular Diseases | Vascular Diseases | Acute Myocardial InfarctionRussian Federation
-
UMC UtrechtAZ-VUBTerminatedMinor Intra-uterine AbnormalitiesNetherlands
-
Thomas GardnerJuvenile Diabetes Research FoundationCompleted
-
University of PittsburghTu Du HospitalCompleted
-
Par Pharmaceutical, Inc.AnapharmCompletedTo Determine Bioequivalence Under Fed ConditionsCanada